LifeSiteNews has been permanently banned on YouTube. Click HERE to sign up to receive emails when we add to our video library.
March 26, 2021 (LifeSiteNews) — American biotechnology company Moderna, developer of one of the country’s two mRNA experimental vaccines for COVID-19, has announced plans to create a hybrid vaccine that will target both COVID and influenza, again using its new mRNA technology.
Moderna CEO Stéphane Bancel made the announcement during The Wall Street Journal’s Health Forum, where he said the efficacy of flu vaccines would be aided by being developed with mRNA technology and could be on the market in just a couple of years. The dual vaccine would be required to go through the Food and Drug Administration’s (FDA) standard approval procedures before being authorized for use, contrasting with the “emergency use authorization” granted to its mRNA COVID-19 jab in December 2020, a week after Pfizer had their equivalent shot approved.
Bancel suggested that the dual vaccine will help immunize people from both COVID and the flu. It would be necessary, he anticipated, to guard against both on an annual basis. The Moderna executive predicted that “more concerning mutations of the new coronavirus” will begin emerging over
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors